Foghorn Therapeutics Inc. Other Accrued Liabilities, Current
Foghorn Therapeutics Inc. (FHTX) had Other Accrued Liabilities, Current of $408.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Accrued Liabilities, Current $408.00K.
- 2026-03-31: Other Accrued Liabilities, Current $437.00K.
- 2025-12-31: Other Accrued Liabilities, Current $400.00K.
- 2025-09-30: Other Accrued Liabilities, Current $396.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $408.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $437.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $400.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $396.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $392.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $526.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.00K 10-K · filed 2026-03-11 | |
| 2024-09-30 | $213.00K 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $239.00K 10-Q · filed 2024-08-08 | |
| 2023-12-31 | $36.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $301.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $94.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $135.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $318.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $324.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $272.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $230.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $392.00K 10-K · filed 2023-03-09 | $379.00K 10-K · filed 2022-03-10 |
| 2021-09-30 | $108.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $138.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $138.00K 10-K/A · filed 2022-08-09 | |
| 2020-09-30 | $587.00K 10-Q · filed 2020-12-04 | |
| 2019-12-31 | $57.00K 10-K · filed 2021-03-18 | $331.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |